sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Europe Pharmaceutical Manufacturing Industry 2020-2027 by Formulation, Route of Administration, Age Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility, and Country: Trend Forecast and Growth Opportunity

Europe Pharmaceutical Manufacturing Industry 2020-2027 by Formulation, Route of Administration,...

Home / Categories / Healthcare
Europe Pharmaceutical Manufacturing Industry 2020-2027 by Formulation, Route of Administration, Age Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility, and Country: Trend Forecast and Growth Opportunity
Europe Pharmaceutical Manufacturing Industry 2020-2027...
Report Code
RO1/105/1112

Publish Date
28/Mar/2024

Pages
131
PRICE
$ 2700/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 4000/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 5400/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Table 1. Snapshot of Europe Pharmaceutical Manufacturing Industry in Balanced Perspective, 2020-2027 18
Table 2. Growth Rate of World Real GDP, 2017-2021 22
Table 3. Main Product Trends and Industry Opportunities in Europe Pharmaceutical Manufacturing Industry 32
Table 4. Europe Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn 40
Table 5. Europe Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn 49
Table 6. Europe Pharmaceutical Manufacturing Industry by Age Group, 2017-2027, $ bn 56
Table 7. Europe Pharmaceutical Manufacturing Industry by Therapeutic Application, 2017-2027, $ bn 61
Table 8. Europe Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn 71
Table 9. Europe Pharmaceutical Manufacturing Industry by Distribution Channels, 2017-2027, $ bn 76
Table 10. Europe Pharmaceutical Manufacturing Industry by Manufacturing Facility, 2017-2027, $ bn 80
Table 11. Europe Pharmaceutical Manufacturing Industry by Country, 2017-2027, $ bn 86
Table 12. UK Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn 88
Table 13. UK Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn 88
Table 14. UK Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn 88
Table 15. France Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn 90
Table 16. France Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn 90
Table 17. France Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn 90
Table 18. Germany Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn 92
Table 19. Germany Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn 92
Table 20. Germany Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn 92
Table 21. Spain Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn 94
Table 22. Spain Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn 94
Table 23. Spain Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn 94
Table 24. Italy Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn 96
Table 25. Italy Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn 96
Table 26. Italy Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn 96
Table 27. Russia Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn 98
Table 28. Russia Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn 98
Table 29. Russia Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn 98
Table 30. Pharmaceutical Manufacturing Industry in Rest of Europe by Country, 2017-2027, $ bn 100
Table 31. Abbott Laboratories: Company Snapshot 105
Table 32. Abbott Laboratories: Business Segmentation 105
Table 33. Abbott Laboratories: Product Portfolio 106
Table 34. Abbott Laboratories: Revenue, 2017-2019, $ bn 106
Table 35. Risk Evaluation for Investing in Europe Industry, 2020-2027 126
Table 36. Critical Success Factors and Key Takeaways 129

LIST OF FIGURE
Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Industry Estimation 15
Figure 4. Europe Industry Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027 17
Figure 5. Europe Pharmaceutical Manufacturing Industry, 2017-2027, $ bn 20
Figure 6. Impact of COVID-19 on Business 24
Figure 7. Primary Drivers and Impact Factors of Europe Pharmaceutical Manufacturing Industry 26
Figure 8. Primary Restraints and Impact Factors of Europe Pharmaceutical Manufacturing Industry 29
Figure 9. Investment Opportunity Analysis 33
Figure 10. Porter's Fiver Forces Analysis of Europe Pharmaceutical Manufacturing Industry 36
Figure 11. Breakdown of Europe Pharmaceutical Manufacturing Industry by Formulation, 2020-2027, % of Revenue 41
Figure 12. Contribution to Europe 2021-2027 Cumulative Revenue by Formulation, Value ($ bn) and Share (%) 41
Figure 13. Europe Pharmaceutical Manufacturing Industry: Tablets, 2017-2027, $ bn 42
Figure 14. Europe Pharmaceutical Manufacturing Industry: Capsules, 2017-2027, $ bn 43
Figure 15. Europe Pharmaceutical Manufacturing Industry: Injectable, 2017-2027, $ bn 44
Figure 16. Europe Pharmaceutical Manufacturing Industry: Sprays, 2017-2027, $ bn 45
Figure 17. Europe Pharmaceutical Manufacturing Industry: Suspensions, 2017-2027, $ bn 46
Figure 18. Europe Pharmaceutical Manufacturing Industry: Powders, 2017-2027, $ bn 47
Figure 19. Europe Pharmaceutical Manufacturing Industry: Other Formulations, 2017-2027, $ bn 48
Figure 20. Breakdown of Europe Pharmaceutical Manufacturing Industry by Route of Administration, 2020-2027, % of Revenue 50
Figure 21. Contribution to Europe 2021-2027 Cumulative Revenue by Route of Administration, Value ($ bn) and Share (%) 50
Figure 22. Europe Pharmaceutical Manufacturing Industry: Oral Medicine, 2017-2027, $ bn 51
Figure 23. Europe Pharmaceutical Manufacturing Industry: Topical Medicine, 2017-2027, $ bn 52
Figure 24. Europe Pharmaceutical Manufacturing Industry: Parenteral Medicine, 2017-2027, $ bn 53
Figure 25. Europe Pharmaceutical Manufacturing Industry: Inhalations, 2017-2027, $ bn 54
Figure 26. Europe Pharmaceutical Manufacturing Industry: Other Routes of Administration, 2017-2027, $ bn 55
Figure 27. Breakdown of Europe Pharmaceutical Manufacturing Industry by Age Group, 2020-2027, % of Revenue 56
Figure 28. Contribution to Europe 2021-2027 Cumulative Revenue by Age Group, Value ($ bn) and Share (%) 57
Figure 29. Europe Pharmaceutical Manufacturing Industry: Children & Adolescents, 2017-2027, $ bn 58
Figure 30. Europe Pharmaceutical Manufacturing Industry: Adults, 2017-2027, $ bn 59
Figure 31. Europe Pharmaceutical Manufacturing Industry: Geriatric, 2017-2027, $ bn 60
Figure 32. Breakdown of Europe Pharmaceutical Manufacturing Industry by Therapeutic Application, 2020-2027, % of Revenue 62
Figure 33. Contribution to Europe 2021-2027 Cumulative Revenue by Therapeutic Application, Value ($ bn) and Share (%) 62
Figure 34. Europe Pharmaceutical Manufacturing Industry: Cardiovascular Diseases, 2017-2027, $ bn 63
Figure 35. Europe Pharmaceutical Manufacturing Industry: Pain, 2017-2027, $ bn 64
Figure 36. Europe Pharmaceutical Manufacturing Industry: Diabetes, 2017-2027, $ bn 65
Figure 37. Europe Pharmaceutical Manufacturing Industry: Cancer, 2017-2027, $ bn 66
Figure 38. Europe Pharmaceutical Manufacturing Industry: Respiratory Diseases, 2017-2027, $ bn 67
Figure 39. Europe Pharmaceutical Manufacturing Industry: Neurological Diseases, 2017-2027, $ bn 68
Figure 40. Europe Pharmaceutical Manufacturing Industry: Orthopedics, 2017-2027, $ bn 69
Figure 41. Europe Pharmaceutical Manufacturing Industry: Other Applications, 2017-2027, $ bn 70
Figure 42. Breakdown of Europe Pharmaceutical Manufacturing Industry by Drug Type, 2020-2027, % of Revenue 71
Figure 43. Contribution to Europe 2021-2027 Cumulative Revenue by Drug Type, Value ($ bn) and Share (%) 72
Figure 44. Europe Pharmaceutical Manufacturing Industry: Branded Prescription Drugs, 2017-2027, $ bn 73
Figure 45. Europe Pharmaceutical Manufacturing Industry: Generic Prescription Drugs, 2017-2027, $ bn 74
Figure 46. Europe Pharmaceutical Manufacturing Industry: OTC Drugs, 2017-2027, $ bn 75
Figure 47. Breakdown of Europe Pharmaceutical Manufacturing Industry by Distribution Channels, 2020-2027, % of Revenue 76
Figure 48. Contribution to Europe 2021-2027 Cumulative Revenue by Distribution Channels, Value ($ bn) and Share (%) 77
Figure 49. Europe Pharmaceutical Manufacturing Industry: Retail Channels, 2017-2027, $ bn 78
Figure 50. Europe Pharmaceutical Manufacturing Industry: Non-retail Channels, 2017-2027, $ bn 79
Figure 51. Breakdown of Europe Pharmaceutical Manufacturing Industry by Manufacturing Facility, 2020-2027, % of Revenue 81
Figure 52. Contribution to Europe 2021-2027 Cumulative Revenue by Manufacturing Facility, Value ($ bn) and Share (%) 81
Figure 53. Europe Pharmaceutical Manufacturing Industry: In-house Facility, 2017-2027, $ bn 82
Figure 54. Europe Pharmaceutical Manufacturing Industry: Outsourced Facility, 2017-2027, $ bn 83
Figure 55. Breakdown of European Pharmaceutical Manufacturing Industry by Country, 2020 and 2027, % of Revenue 85
Figure 56. Contribution to Europe 2021-2027 Cumulative Revenue by Country, Value ($ bn) and Share (%) 86
Figure 57. Pharmaceutical Manufacturing Industry in UK, 2017-2027, $ bn 87
Figure 58. Pharmaceutical Manufacturing Industry in France, 2017-2027, $ bn 89
Figure 59. Pharmaceutical Manufacturing Industry in Germany, 2017-2027, $ bn 91
Figure 60. Pharmaceutical Manufacturing Industry in Spain, 2017-2027, $ bn 93
Figure 61. Pharmaceutical Manufacturing Industry in Italy, 2017-2027, $ bn 95
Figure 62. Pharmaceutical Manufacturing Industry in Russia, 2017-2027, $ bn 97
Figure 63. Pharmaceutical Manufacturing Industry in Rest of Europe, 2017-2027, $ bn 99
Figure 64. Growth Stage of Europe Industrial Robot Software Industry over the Forecast Period 101

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com